Apr 27, 2018 12:00 pm UTC| Business
Presented inarigivir 25 mg and 50mg cohorts from Phase 2 ACHIEVE trial in chronic hepatitis B patients at two scientific conferences Continues to advance SB 11285, a next-generation STING agonist, towards clinical trial ...
First Capital, Inc. Reports Quarterly Earnings Increase
Apr 27, 2018 12:00 pm UTC| Business
CORYDON, Ind., April 27, 2018 -- First Capital, Inc. (the “Company”) (NASDAQ:FCAP), the holding company for First Harrison Bank (the “Bank”), today reported net income of $2.1 million or $0.64 per diluted share for the...
Acasti Pharma Appoints Donald Olds to its Board of Directors and Audit Committee
Apr 27, 2018 12:00 pm UTC| Business
LAVAL, Qubec, April 27, 2018 -- Acasti Pharma Inc. (NASDAQ:ACST) (TSX-V:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3...
Apr 27, 2018 12:00 pm UTC| Business
LEXINGTON, Mass., April 27, 2018 -- Mimecast Limited (NASDAQ:MIME), a leading email and data security company, today announced that Peter Campbell, Mimecast Chief Financial Officer, will present at the J.P. Morgan 46th...
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
Apr 27, 2018 12:00 pm UTC| Business
WALTHAM, Mass., April 27, 2018 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences: Deutsche Bank Annual Health Care...
Apr 27, 2018 12:00 pm UTC| Business
NEW YORK, April 27, 2018 -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies, today announced the enrollment and successful completion of...
Apr 27, 2018 12:00 pm UTC| Business
PHOENIX, April 27, 2018 -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, recently initiated a Phase 2...